Human Nasal Decongestant Shows Promise for Canine Surgical Comfort

A recent investigation by Dr. Jun-Yan Sek, a small‑animal surgical registrar at JCUVet and lecturer at James Cook University, suggests that a common human nasal spray containing xylometazoline hydrochloride could improve conditions for dogs undergoing surgery. The study examined whether the vasoconstrictive properties of the medication, traditionally used to reduce nasal congestion in people, might help manage bleeding and airway swelling in canine patients during operative procedures.

The research team administered the spray to a group of dogs scheduled for routine surgeries and monitored intra‑operative bleeding, visibility of the surgical field, and post‑operative recovery markers. Preliminary results indicated a modest reduction in mucosal blood flow, which translated into clearer operative sites and potentially shorter anesthesia times. While the sample size was limited, the findings point to a low‑cost, readily available adjunct that could enhance veterinary surgical protocols.

Veterinary anesthesiology often relies on a narrow range of medications approved specifically for animals, and off‑label use of human drugs must be approached with caution. Xylometazoline’s mechanism—constricting blood vessels in the nasal mucosa—has been well documented in human medicine, but its effects on canine tissue have received little formal study until now. Dr. Sek emphasized that the spray was applied topically and in doses adjusted for the size of each animal, reducing the risk of systemic absorption.

Experts in the field note that controlling intra‑nasal bleeding is especially relevant for procedures involving the upper airway, such as dental extractions, rhinoscopy, and certain orthopedic surgeries where positioning can affect nasal blood flow. If further trials confirm the initial observations, the spray could become a standard pre‑operative preparation, offering an alternative to more invasive pharmacological interventions.

The next phase of the research will involve larger, multi‑center trials to assess safety, optimal dosing, and any potential side effects across different breeds and age groups. Regulatory approval for veterinary use would still be required, but the study highlights how repurposing existing human medications can fill gaps in animal care. For now, veterinarians are advised to await robust evidence before incorporating the spray into routine practice, while the veterinary community watches closely for updates from Dr. Sek’s team.